Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Cancer Medicine|April 16, 2023
Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patientsMasahiro Torasawa, Tatsuya Yoshida, Yuki Takeyasu, et al.
Proteins|July 11, 2008
Solution structure of the GUCT domain from human RNA helicase II/Gu beta reveals the RRM fold, but implausible RNA interactionsSatoshi Ohnishi, Kimmo Pääkkönen, Seizo Koshiba, et al.
Nucleic Acids Research|July 22, 2008
The RRM domain of poly(A)-specific ribonuclease has a noncanonical binding site for mRNA cap analog recognitionTakashi Nagata, Sakura Suzuki, Ryuta Endo, et al.
Biomolecular NMR Assignments|December 8, 2025
1H, 13C, and 15N resonance assignments and solution structure of the CID domain of SR-related- and CTD-associated factor 8 (SCAF8)Weirong Dang, Yutaka Muto, Fahu He, et al.
Biomolecular NMR Assignments|March 29, 2024
1H, 13C, and 15N resonance assignments and solution structure of the N-terminal divergent calponin homology (NN-CH) domain of human intraflagellar transport protein 54Kanako Kuwasako, Weirong Dang, Fahu He, et al.
Respiratory Investigation|April 7, 2022
Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosisYutaka Muto, Akimasa Sekine, Eri Hagiwara, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2026
Comparative analysis of therapeutic target protein expression in de novo and transformed small cell lung carcinomas using paired biopsy samplesSaori Murata, Jumpei Kashima, Hidehito Horinouchi, et al.
Clinical Lung Cancer|June 1, 2022
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC PatientsYukiko Shimoda, Ryota Shibaki, Tatsuya Yoshida, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2024
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trialSeiji Niho, Jun Sato, Miyako Satouchi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2023
Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancerKazumasa Akagi, Shigehiro Yagishita, Mayu Ohuchi, et al.
Pageof 27